Chemerin Receptor

趋化素受体是能与趋化素特异性结合的一类膜受体,属于 G 蛋白偶联受体家族,归类为 Class A。目前趋化素受体主要有趋化素受体 1,也称为 ChemR23 或 CMKLR1 和趋化素受体 2 ,也称为 GPR1。趋化素与其受体结合后,可招募并激活免疫细胞,增强机体的固有免疫和适应性免疫反应。同时,也可以调节血管内皮细胞的功能,促进血管生成。趋化素受体也参与能量代谢和脂肪组织的调节。趋化素及其受体表达和功能的异常与肿瘤、炎症性疾病和肥胖、糖尿病等代谢性疾病密切相关[1][2]。

Chemerin receptors are a type of membrane receptors that can specifically bind to chemerin and belong to the G-protein-coupled receptor family Class A. Currently, the main chemerin receptors include chemerin receptor 1, also known as ChemR23 or CMKLR1, and chemerin receptor 2, also known as GPR1. After chemerin binds to its receptor, it can recruit and activate immune cells, enhancing the body's innate and adaptive immune responses. At the same time, it can also regulate the functions of vascular endothelial cells and promote angiogenesis. Chemerin receptors are also involved in the regulation of energy metabolism and adipose tissue. Abnormalities in the expression and function of chemerin and its receptors are closely related to cancer, inflammatory diseases, and metabolic diseases such as obesity and diabetes[1][2].

Chemerin Receptor亚型特异性产品:Chemerin Receptor Isoform Comparison
共 1种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
Urcosimod
OK 101

Urcosimod(OK 101)是一种脂质偶联的趋化素肽,作为 ChemR23 G 蛋白偶联受体激动剂,已被证实具有抗炎与镇痛活性,并可用于干眼症研究。

1610366-43-2
Agonist
96.76%
Urcosimod

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础